SCHEMBL2827522

SCHEMBL2827522

CCO/C(Cc1ccccc1F)=N/C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAOB P27338 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
CNR2 P34972 1/20 0.34
IDO1 P14902 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2827524 1.00 ALDH1A1 (0.40) ALDH1A1POLBKDM4EL3MBTL1KMT2A
SCHEMBL5342412 0.85 CTBP2 (0.40) ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL5342416 0.85 CTBP2 (0.40) ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL2824235 0.83 ALDH1A1 (0.40) ALDH1A1POLBKMT2AMEN1RAB9A
SCHEMBL2824238 0.83 ALDH1A1 (0.40) ALDH1A1POLBKMT2AMEN1RAB9A
SCHEMBL5352600 0.82 ALDH1A1 (0.40) ALDH1A1KDM4EL3MBTL1KMT2ANPC1
SCHEMBL5352596 0.82 ALDH1A1 (0.40) ALDH1A1KDM4EL3MBTL1KMT2ANPC1
SCHEMBL5344132 0.82 POLQ (0.43) ALDH1A1KDM4EMAOBIDO1
SCHEMBL5344128 0.82 POLQ (0.43) ALDH1A1KDM4EMAOBIDO1
SCHEMBL5337175 0.77 FFAR1 (0.38) ALDH1A1KDM4EKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507493-B2 Amide and amidine derivatives and uses thereof ABBVIE INC. (US) 2013-08-13 US disclosed
EP-2243479-A2 Novel amide and amidine derivates and uses thereof Abbott Laboratories (US) 2010-10-27 EP disclosed
US-20100267738-A1 NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF ABBOTT LABORATORIES (US) 2010-10-21 US disclosed
US-20070232686-A1 Cyanoamidine P2X7 Antagonists for the Treatment of Pain CARROLL WILLIAM A 2007-10-04 US disclosed
US-7241776-B2 Cyanoamidine P2X7 antagonists for the treatment of pain ABBOTT LABORATORIES (US) 2007-07-10 US disclosed
US-20060025614-A1 Cyanoamidine P2X7 antagonists for the treatment of pain ABBVIE INC. 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267738-A1 NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF HSD11B2, HSD11B1, HSD17B2 ALDH1A1 935/4885POLB 3614/4885KDM4E 4025/4885
US-20060025614-A1 Cyanoamidine P2X7 antagonists for the treatment of pain P2RX2, P2RX1, P2RX7 ALDH1A1 3848/4885POLB 4148/4885KDM4E 3687/4885
US-20070232686-A1 Cyanoamidine P2X7 Antagonists for the Treatment of Pain P2RX2, P2RX1, P2RX7 ALDH1A1 3848/4885POLB 4148/4885KDM4E 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.